Beam Therapeutics Inc. (BEAM) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Beam Therapeutics Inc.
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous…
Source: Yahoo Finance
Sector & Industry
Beam Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Beam Therapeutics Inc. at a Glance
| Company | Beam Therapeutics Inc. |
| Ticker | BEAM |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $29.66 |
| Market cap | $3.06B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.69 |
| 52-week high | $38.26 |
| 52-week low | $19.36 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.23 |
| Return on equity (ROE) | -8.18% |
| Debt-to-equity | 23.17% |
| Average volume | 2.06M |
| Shares outstanding | 103.29M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 540 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Beam Therapeutics Inc.'s current P/E ratio?
- Beam Therapeutics Inc. (BEAM) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Beam Therapeutics Inc.'s market capitalisation?
- Beam Therapeutics Inc.'s market cap is $3.06B based on our latest snapshot. See how it ranks by market cap →
- What is BEAM's 52-week range?
- Over the past 52 weeks, BEAM has traded between $19.36 and $38.26. What does the 52-week range mean? →
- How volatile is Beam Therapeutics Inc. compared to the market?
- Beam Therapeutics Inc. has a beta of 2.23, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Beam Therapeutics Inc. pay a dividend?
- Beam Therapeutics Inc. does not currently pay a dividend according to our latest data.
- What exchange is BEAM listed on?
- BEAM is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Beam Therapeutics Inc. in?
- Beam Therapeutics Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →